000			01500 a2200421 4500
005			20250513150107.0
264		0	_c19981028
008			199810s 0 0 eng d
022			_a0033-3158
024	7		_a10.1007/s002130050621 _2doi
040			_aNLM _beng _cNLM
100	1		_aCollins, R L
245	0	0	_aKappa opioid-mediated behavioral sensitization in the preweanling rat: relationship to Fos immunoreactivity. _h[electronic resource]
260			_bPsychopharmacology _cJun 1998
300			_a282-91 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_a3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer _xpharmacology
650	0	4	_aAnalgesics, Non-Narcotic _xpharmacology
650	0	4	_aAnimals
650	0	4	_aAnimals, Newborn
650	0	4	_aArousal _xdrug effects
650	0	4	_aBrain _xdrug effects
650	0	4	_aBrain Mapping
650	0	4	_aFemale
650	0	4	_aMale
650	0	4	_aMotor Activity _xdrug effects
650	0	4	_aProto-Oncogene Proteins c-fos _xmetabolism
650	0	4	_aRats
650	0	4	_aRats, Sprague-Dawley
650	0	4	_aReceptors, Opioid, kappa _xdrug effects
700	1		_aZavala, A R
700	1		_aIngersoll, V Y
700	1		_aDuke, M A
700	1		_aCrawford, C A
700	1		_aMcDougall, S A
773	0		_tPsychopharmacology _gvol. 137 _gno. 3 _gp. 282-91
856	4	0	_uhttps://doi.org/10.1007/s002130050621 _zAvailable from publisher's website
999			_c9648756 _d9648756